[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343054-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343054-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","manuka-honey-inhibits-human-breast-cancer-progression-in-preclinical-models-nutrients-article","Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models - Nutrients Article","","Manuka honey (MH) demonstrates potential antitumor activity in preclinical models of human breast cancer. In vitro, MH at 0.3–5.0%(w/v) produced significant, dose-dependent inhibition of MCF-7 cell proliferation, with weaker effects in MDA-MB-231 cells. MH reduced MCF-7 proliferation but did not affect non-malignant HMECs. Mechanistically, MH induced apoptosis in MCF-7 cells with PARP activation, activated AMPK, and inhibited AKT/mTOR downstream signaling, including reduced STAT3 phosphorylation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/manuka-honey-inhibits-human-breast-cancer-progression-in-preclinical-models-nutrients-article/343054/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/manuka-honey-inhibits-human-breast-cancer-progression-in-preclinical-models-nutrients-article/343054.png","ImageObject",300,407,{"name":42,"@type":43},"Oliver","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does manuka honey affect MCF-7 and MDA-MB-231 breast cancer cells in vitro?","Question",{"text":63,"@type":64},"Manuka honey (0.3–5.0% w/v) inhibits proliferation of MCF-7 cells in a dose-dependent manner. Its anti-proliferative effects are less pronounced in MDA-MB-231 cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Does manuka honey selectively affect cancer cells versus non-malignant cells?",{"text":68,"@type":64},"MH reduces MCF-7 proliferation but does not reduce proliferation in non-malignant human mammary epithelial cells (HMECs) at 2.5% w/v.",{"name":70,"@type":61,"acceptedAnswer":71},"What molecular pathways are implicated in MH’s antitumor activity?",{"text":72,"@type":64},"MH stimulates apoptosis correlated with PARP activation and activates AMPK while inhibiting AKT/mTOR downstream signaling. It also reduces phosphorylated STAT3 levels in vitro.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343054,1790468016,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","nutrients   \nArticle  \nManuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models  \nDiana C. Márquez-Garbán 1,2, *, Cristian D. Yanes 1,2, Gabriela Llarena 1,2, David Elashoff 2,3, Nalo Hamilton 2,4, Mary Hardy 2,3, Madhuri Wadehra 2,5, Susan A. McCloskey 2,6 and Richard J. Pietras 1,2  \nCitation: Márquez-Garbán, D.C.; Yanes, C.D.; Llarena, G.; Elashoff, D.; Hamilton, N.; Hardy, M.; Wadehra, M.; McCloskey, S.A.; Pietras, R.J. Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models. Nutrients 2024, 16, 2369. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)nu16142369  \nAcademic Editor: Dominique Delmas  \nReceived: 11 June 2024  \nRevised: 10 July 2024  \nAccepted: 12 July 2024  \nPublished: 22 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA; [rpietras@mednet.ucla.edu](rpietras@mednet.ucla.edu) (R.J.P.)  \n2 UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA;  \n[delashoff@mednet.ucla.edu](delashoff@mednet.ucla.edu) (D.E.); [mary@maryhardy.com](mary@maryhardy.com) (M.H.)  \n3 Division of General Internal Medicine, Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA  \n4 School of Nursing, UCLA, Los Angeles, CA 90095, USA  \n5 Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA  \n6 Department of Radiation Oncology, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA  \n* Correspondence: [dmarquez@mednet.ucla.edu](dmarquez@mednet.ucla.edu); Tel.: +1-310-825-9767  \nAbstract: Manuka honey (MH) exhibits potential antitumor activity in preclinical models of a number of human cancers. Treatment in vitro with MH at concentrations ranging from 0.3 to 5.0%(w /v) led to significant dose-dependent inhibition of proliferation of human breast cancer MCF- 7 cells, but anti-proliferative effects of MH were less pronounced in MDA-MB-231 breast cancer cells. Effects of MH were also tested on non-malignant human mammary epithelial cells (HMECs) at 2.5% w /v, and it was found that MH reduced the proliferation of MCF-7 cells but not that of HMECs. Notably, the antitumor activity of MH was in the range of that exerted by treatment of MCF-7 cells with the antiestrogen tamoxifen. Further, MH treatment stimulated apoptosis of MCF-7 cells in vitro, with most cells exhibiting acute and significant levels of apoptosis that correlated with PARP activation. Additionally, the effects of MH induced the activation of AMPK and inhibition of AKT/mTOR downstream signaling. Treatment of MCF7 cells with increased concentrations of MH induced AMPK phosphorylation in a dose-dependent manner that was accompanied by inhibition of phosphorylation of AKT and mTOR downstream effector protein S6 . In addition, MH reduced phosphorylated STAT3 levels in vitro, which may correlate with MH and AMPK-mediated antiinflammatory properties. Further, in vivo, MH administered alone significantly inhibited the growth of established MCF-7 tumors in nude mice by 84%, resulting in an observable reduction in tumor volume. Our findings highlight the need for further research into the use of natural compounds, such as MH, for antitumor efficacy and potential chemoprevention and investigation of molecular pathways underlying these actions.  \nKeywords: Manuka honey; breast cancer; estrogen receptor-positive breast cancer; triple-negative breast cancer; in vivo xenografts; AMP kinase signaling; mTOR; STAT3  \n1. Introduction  \nBreast cancer (BC) is a leading cause of de","cbCaiuvw5OhjyVpI","https://ap.wps.com/l/cbCaiuvw5OhjyVpI","pdf",1509575,13,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"How does manuka honey affect MCF-7 and MDA-MB-231 breast cancer cells in vitro?\",\"answer\":\"Manuka honey (0.3–5.0% w/v) inhibits proliferation of MCF-7 cells in a dose-dependent manner. Its anti-proliferative effects are less pronounced in MDA-MB-231 cells.\"},{\"question\":\"Does manuka honey selectively affect cancer cells versus non-malignant cells?\",\"answer\":\"MH reduces MCF-7 proliferation but does not reduce proliferation in non-malignant human mammary epithelial cells (HMECs) at 2.5% w/v.\"},{\"question\":\"What molecular pathways are implicated in MH’s antitumor activity?\",\"answer\":\"MH stimulates apoptosis correlated with PARP activation and activates AMPK while inhibiting AKT/mTOR downstream signaling. It also reduces phosphorylated STAT3 levels in vitro.\"}]","Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models - Nutrients Article | PDF",1790049619,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab104215ccd6b44e86d5bed9a04b4a1c.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1c6e469d1fe3b323558eb4a909a2c04.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c05e96414cf930ba2d8b384d31793fc.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a96b583def23c5bb9d463083c20a6e0.webp",980,1385]